The legacy success of sildenafil has undeniably transformed the healthcare landscape. However, investing in companies heavily reliant on copycat drugs and the declining patent exclusivity surrounding this https://ilovebookmark.com/story21235261/the-blue-pill-and-pharmaceutical-companies-a-uncertain-opportunity